Comparing Mesalamine vs Remicade
| Mesalamine | Remicade (infliximab) |
|
|---|
| Mesalamine | Remicade (infliximab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Crohn's Disease - Maintenance, Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Proctitis... View more |
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease, Ankylosing Spondylitis, Crohn's Disease - Active, Inflammatory Bowel Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Ulcerative Colitis
Crohn's Disease
Ulcerative Colitis, Maintenance
Inflammatory Bowel Disease
|
|||||||||||||||
| More about Mesalamine | More about Remicade (infliximab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Mesalamine has an average rating of 7.0 out of 10 from a total of 426 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 20% reported a negative effect. |
Remicade has an average rating of 7.0 out of 10 from a total of 213 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Mesalamine side effects |
View all Remicade side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mesalamine prices |
View all Remicade prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | Other infliximab brands include: Avsola, Inflectra, Ixifi, Renflexis, Zymfentra | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
10 hours |
228 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 121 drugs are known to interact with Mesalamine:
|
A total of 568 drugs are known to interact with Remicade:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 24, 1987 |
August 24, 1998 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.